What this means
This trial plans to find safe pain medicine doses for older patients who are frail. It has not started recruiting and has no results yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 65 and over
- Where
- Not listed
The science
- Registered title
- Impact of Frailty on Nalbuphine Dose for Postoperative Analgesia in Elderly Patients Undergoing Laparoscopic GI Surgery
- Trial ID
- NCT06953570 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- PCIA, Frailty, Laparoscopic Gastrointestinal Surgery
- Sponsor
- Yongtao Sun
- Ages
- 65 Years to no maximum
- Dates
- First posted May 1, 2025 · updated May 1, 2025
Registry summary
This study aims to investigate the ED50 and ED95 of nalbuphine combined with dexmedetomidine in patient-controlled intravenous analgesia (PCIA) for elderly patients with different degrees of frailty, as well as their analgesic effects and complications. The results of this study can provide safe and effective dosage guidance for postoperative analgesia in frail patients, help optimize analgesic regimens, reduce the risk of complications, and improve the quality of postoperative recovery.